BRIEF published on 05/14/2024 at 12:35, 2 years 1 month ago Reply SpA annonce une croissance financière positive au premier trimestre 2024 Performance Financière Intelligence Artificielle Hausse Des Revenus Répondre SpA Résultats Financiers Du Premier Trimestre 2024
PRESS RELEASE published on 05/14/2024 at 12:30, 2 years 1 month ago Reply: The Board of Directors approves the quarterly report dated 31 March 2024 Reply S.p.A.'s Board of Directors approves the positive quarterly report as at 31 March 2024, showing growth in all economic and financial indicators Financial Results EBITDA Artificial Intelligence Quarterly Report Reply S.p.A.
BRIEF published on 03/13/2024 at 13:46, 2 years 3 months ago REPLY Announces Strong Financial Performance in 2023 and Declares Dividend Financial Results Artificial Intelligence Technology Sector Dividend Announcement Reply SpA
BRIEF published on 03/13/2024 at 13:46, 2 years 3 months ago REPLY annonce de solides performances financières en 2023 et déclare un dividende Résultats Financiers Intelligence Artificielle Secteur Technologique Annonce De Dividende Répondre SpA
PRESS RELEASE published on 03/13/2024 at 13:41, 2 years 3 months ago REPLY: The Board of Directors approved the draft financial statements for the year 2023 Reply S.p.A. announces positive financial results for 2023 with a consolidated turnover of €2,118.0 million and proposed dividend distribution of €1 per share Financial Results 2023 Dividend Distribution Reply S.p.A. Positive Indicators
PRESS RELEASE published on 11/10/2023 at 10:31, 2 years 7 months ago Original-Research: Reply S.p.A. (von GBC AG): -
PRESS RELEASE published on 11/09/2023 at 10:01, 2 years 7 months ago Original-Research: Reply S.p.A. (von GBC AG): -
PRESS RELEASE published on 08/01/2023 at 12:43, 2 years 10 months ago Reply SpA: : The Board of Directors approves the half-year financial report as of 30 June 2023
PRESS RELEASE published on 05/15/2023 at 12:09, 3 years 1 month ago Reply SpA: The Board of Directors approves the quarterly report dated 31 March 2023
PRESS RELEASE published on 03/14/2023 at 13:40, 3 years 3 months ago Reply SpA: The Board of Directors approved the draft financial statements for the year 2022
Published on 06/26/2026 at 01:40, 9 hours 23 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 11 hours 33 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 12 hours 33 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 13 hours 31 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 19 hours 33 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 10:50, 13 minutes ago Indotek Group acquires remaining 53% stake in Auchan Hungary, assumes full ownership
Published on 06/26/2026 at 10:47, 16 minutes ago flatexDEGIRO accelerates its growth trajectory and expects to achieve its 2027 financial targets already in 2026, one year ahead of schedule
Published on 06/26/2026 at 10:44, 18 minutes ago EQS-Adhoc: flatexDEGIRO SE: Full-year 2026 guidance raised, financial targets originally set for 2027 expected to be achieved already in 2026, one year ahead of time
Published on 06/26/2026 at 10:30, 33 minutes ago Uniper and Skyborn Renewables sign offshore wind PPA
Published on 06/26/2026 at 10:25, 38 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 06/26/2026 at 07:00, 4 hours 3 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 4 hours 3 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 16 hours 18 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 16 hours 33 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 17 hours 13 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
